In standard care, hemodialysis patients are often treated with a center-specific fixed dialysate sodium concentration, potentially resulting in diffusive sodium changes for patients with plasma sodium concentrations below or above this level. While diffusive sodium load may be associated with thirst and higher interdialytic weight gain, excessive diffusive sodium removal may cause intradialytic symptoms. In contrast, the new hemodialysis machine option "Na control" provides automated individualization of dialysate sodium during treatment with the aim to reduce such intradialytic sodium changes without the need to determine the plasma sodium concentration. This proof-of-principle study on sodium control was designed as a monocentric randomized controlled crossover trial: 32 patients with residual diuresis of ≤1000 mL/day were enrolled to be treated by high-volume post-dilution hemodiafiltration (HDF) for 2 weeks each with "Na control" (individually and automatically adjusted dialysate sodium concentration) versus "standard fixed Na" (fixed dialysate sodium 138 mmol/L), in randomized order. Pre- and post-dialytic plasma sodium concentrations were determined at bedside by direct potentiometry. The study hypothesis consisted of 2 components: the mean plasma sodium change between the start and end of the treatment being within ±1.0 mmol/L for sodium-controlled treatments, and a lower variability of the plasma sodium changes for "Na control" than for "standard fixed Na" treatments. Three hundred seventy-two treatments of 31 adult chronic hemodialysis patients (intention-to-treat population) were analyzed. The estimate for the mean plasma sodium change was -0.53 mmol/L (95% confidence interval: [-1.04; -0.02] mmol/L) for "Na control" treatments and -0.95 mmol/L (95% CI: [-1.76; -0.15] mmol/L) for "standard fixed Na" treatments. The standard deviation of the plasma sodium changes was 1.39 mmol/L for "Na control" versus 2.19 mmol/L for "standard fixed Na" treatments (P = 0.0004). Whereas the 95% CI for the estimate for the mean plasma sodium change during "Na control" treatments marginally overlapped the lower border of the predefined margin ±1.0 mmol/L, the variability of intradialytic plasma sodium changes was lower during "Na control" versus "standard fixed Na" treatments. Thus, automated dialysate sodium individualization by "Na control" approaches isonatremic dialysis in the clinical setting.

Faculty of Mechatronics and Medical Engineering Ulm University of Applied Sciences Ulm Germany

Fresenius Medical Care Deutschland GmbH Bad Homburg Germany

Fresenius Medical Care DS s r o Prague 6 Czech Republic

Zobrazit více v PubMed

Charra B, Chazot C, Jean G, Hurot JM, Terrat JC, Vanel T, et al. Role of sodium in dialysis. Minerva Urol Nefrol 2004;56:205–13. PubMed

Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, et al. Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol 2012;7:92–100. PubMed PMC

Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol 2017;28:2491–7. PubMed PMC

Lindley EJ. Reducing sodium intake in hemodialysis patients. Semin Dial 2009;22:260–3. PubMed

Penne EL, Levin NW, Kotanko P. Improving volume status by comprehensive dietary and dialytic sodium management in chronic hemodialysis patients. Blood Purif 2010;30:71–8. PubMed

Mann H, Stiller S. Sodium modeling. Kidney Int Suppl 2000;76:S79–88. PubMed

Basile C, Lomonte C. It is time to individualize the dialysate sodium prescription. Semin Dial 2016;29:24–7. PubMed

Keen ML, Gotch FA. The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs 2007;30:971–9. PubMed

Basile C, Libutti P, Lisi P, Vernaglione L, Casucci F, Losurdo N, et al. Sodium setpoint and gradient in bicarbonate hemodialysis. J Nephrol 2013;26:1136–42. PubMed

Odudu A, Lambie S, Taal MW, Fluck RJ, McIntyre CW. Use of online conductivity monitoring to study sodium mass balance in chronic haemodialysis patients: prospects for treatment individualisation. Kidney Blood Press Res 2011;34:439–46. PubMed

Zerbe RL, Miller JZ, Robertson GL. The reproducibility and heritability of individual differences in osmoregulatory function in normal human subjects. J Lab Clin Med 1991;117:51–9. PubMed

Flanigan MJ. Role of sodium in hemodialysis. Kidney Int Suppl 2000;76:S72–8. PubMed

Moret K, Hassell D, Kooman JP, et al. Ionic mass balance and blood volume preservation during a high, standard, and individualized dialysate sodium concentration. Nephrol Dial Transplant 2002;17:1463–9. PubMed

Santos SF, Peixoto AJ. Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:522–30. PubMed PMC

Munoz Mendoza J, Sun S, Chertow GM, Moran J, Doss S, Schiller B. Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant 2011;26:1281–7. PubMed PMC

Kim DY, Kim B, Moon KH, Lee S, Lee DY. Effect of gradually lowering dialysate sodium concentration on the interdialytic weight gain, blood pressure, and extracellular water in anuric hemodialysis patients. Ren Fail 2014;36:23–7. PubMed

de Paula FM, Peixoto AJ, Pinto LV, Dorigo D, Patricio PJ, Santos SF. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004;66:1232–8. PubMed

Munoz Mendoza J, Arramreddy R, Schiller B. Dialysate sodium: choosing the optimal hemodialysis bath. Am J Kidney Dis 2015;66:710–20. PubMed

Hanafusa N, Tsuchiya K, Nitta K. Dialysate sodium concentration: the forgotten salt shaker. Semin Dial 2018;31:563–8. PubMed

Flythe JE, Mc Causland FR. Dialysate sodium: rationale for evolution over time. Semin Dial 2017;30:99–111. PubMed PMC

Bosetto A, Bene B, Petitclerc T. Sodium management in dialysis by conductivity. Adv Ren Replace Ther 1999;6:243–54. PubMed

Chevalier L, Tielemans C, Debelle F, Vandervelde D, Fumeron C, Mandart L, et al. Isonatric dialysis biofeedback in hemodiafiltration with online regeneration of ultrafiltrate in hypertensive hemodialysis patients: a randomized controlled study. Blood Purif 2016;41:87–93. PubMed

Kuhlmann U, Maierhofer A, Canaud B, Hoyer J, Gross M. Zero diffusive sodium balance in hemodialysis provided by an algorithm‐based electrolyte balancing controller: a proof of principle clinical study. Artif Organs 2019;43:150–8. PubMed

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015;66:884–930. PubMed

Bogle W, Hsu YS. Sample size determination in comparing two population variances with paired‐data: application to bilirubin tests. Biometrical J 2002;44:594–602.

Kim GH. Pseudohyponatremia: does it matter in current clinical practice? Electrolyte Blood Press 2006;4:77–82. PubMed PMC

Penne EL, Thijssen S, Raimann JG, Levin NW, Kotanko P. Correction of serum sodium for glucose concentration in hemodialysis patients with poor glucose control. Diabetes Care 2010;33:e91. PubMed

Katz MA. Hyperglycemia‐induced hyponatremia–calculation of expected serum sodium depression. N Engl J Med 1973;289:843–4. PubMed

Locatelli F, Stefoni S, Petitclerc T, Coli L, Di Filippo S, Andrulli S, et al. Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study. Nephrol Dial Transplant 2012;27:3935–42. PubMed PMC

Colì L, La Manna G, Comai G, Ursino M, Ricci D, Piccari M, et al. Automatic adaptive system dialysis for hemodialysis‐associated hypotension and intolerance: a noncontrolled multicenter trial. Am J Kidney Dis 2011;58:93–100. PubMed

Petitclerc T, Gaillard F. The different modalities of isonatric hemodialysis. Nephrol Ther 2019;15:22–8. PubMed

Funck‐Brentano JL. Sodium‐free water clearance in hemodialysis. Artif Organs 1981;5:51–3. PubMed

Gross M, Maierhofer A, Tetta C, Senecal L, Canaud B. Online clearance measurement in high‐efficiency hemodiafiltration. Kidney Int 2007;72:1550–3. PubMed

Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance